palmidrol has been researched along with Temporomandibular Disorders in 1 studies
palmidrol: a cannabinoid receptor-inactive eCB-related molecule used as prophylactic in helping to prevent respiratory viral infection
palmitoyl ethanolamide : An N-(long-chain-acyl)ethanolamine that is the ethanolamide of palmitic (hexadecanoic) acid.
Excerpt | Relevance | Reference |
---|---|---|
"To carry out a randomized clinical trial to compare the effect of palmitoylethanolamide (PEA) versus ibuprofen, a nonsteroidal anti-inflammatory drug (NSAID), for pain relief in temporomandibular joint (TMJ) osteoarthritis or arthralgia." | 5.16 | Palmitoylethanolamide versus a nonsteroidal anti-inflammatory drug in the treatment of temporomandibular joint inflammatory pain. ( Bartolucci, ML; Bonetti, GA; Bortolotti, F; Gatto, MR; Marini, I, 2012) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Marini, I | 1 |
Bartolucci, ML | 1 |
Bortolotti, F | 1 |
Gatto, MR | 1 |
Bonetti, GA | 1 |
1 trial available for palmidrol and Temporomandibular Disorders
Article | Year |
---|---|
Palmitoylethanolamide versus a nonsteroidal anti-inflammatory drug in the treatment of temporomandibular joint inflammatory pain.
Topics: Adult; Amides; Anti-Inflammatory Agents, Non-Steroidal; Arthralgia; Double-Blind Method; Endocannabi | 2012 |